PodParley PodParley
PodParley
FDA Priority Review for Post-Neoadjuvant T-DXd in HER2+ Early BC episode artwork

EPISODE · Mar 12, 2026 · 2 MIN

FDA Priority Review for Post-Neoadjuvant T-DXd in HER2+ Early BC

from TheBrief.Health · host TheBrief.Health

The FDA granted Priority Review to trastuzumab deruxtecan for high-risk HER2-positive early breast cancer with residual disease, signaling a potential new standard to reduce recurrence risk.

What this episode covers

The FDA granted Priority Review to trastuzumab deruxtecan for high-risk HER2-positive early breast cancer with residual disease, signaling a potential new standard to reduce recurrence risk.

NOW PLAYING

FDA Priority Review for Post-Neoadjuvant T-DXd in HER2+ Early BC

0:00 2:11

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

Beating loneliness by bridging the generation gap

Apr 21, 2026 ·13m

Robotics and the Future of Aged Care

Apr 19, 2026 ·16m

The Purpose Paradox: Why Baby Boomers Delay Retirement

Apr 17, 2026 ·13m

A Growing Movement Aims to Prepare All Physicians to Care for Older Adults

Apr 15, 2026 ·12m

Defeating Recurring Charges on Cancelled Credit Cards

Apr 13, 2026 ·11m

If Your Dad Has These 11 Odd Habits, He's More Lonely Than He Admits

Apr 11, 2026 ·16m

Similar Podcasts

Eat to Live Jenna Fuhrman, Dr. Fuhrman Our health is our most precious gift and smart nutrition can change your life. Each month, join Dr. Fuhrman and his daughter, Jenna Fuhrman as they discuss important topics in the world of nutrition. Eat to Live will change the way you eat and think about food. Kaizen Blueprint Aldo Chandra "Kaizen" is a Japanese term for continuous improvement. This podcast provides a blueprint to learn about health, wealth, relationships and everything else in between. Through our podcast, we strive to inspire, educate, and motivate our audience to cultivate a mindset of lifelong learning, productivity, and personal development. By sharing insights, strategies, and practical tips, we aim to guide listeners on their journey towards realizing their fullest potential, fostering success, and creating lasting positive change. PodSights Health & Wellness podsights.ai Transform your wellbeing journey. Get trusted, evidence-based answers to your health, fitness, and mental wellness questions. Make informed decisions about your health. Visit podsights.ai to create your own wellness podcast. Tips, News and Stories for Older Adults Esther C Kane CAPS, C.D.S. "Tips, News, and Stories for Older Adults" delivers weekly insights tailored for seniors. We bring you summaries of curated news, practical advice, and inspiring stories that matter to the 55+ community. From health and finance to technology and lifestyle, our content keeps you informed and engaged. Sourced from trusted outlets, each episode offers valuable information for navigating your golden years. Join us as we explore aging with positivity, wisdom, and engaging stories. Your perfect companion for staying active, learning, and embracing life's later chapters.

Frequently Asked Questions

How long is this episode of TheBrief.Health?

This episode is 2 minutes long.

When was this TheBrief.Health episode published?

This episode was published on March 12, 2026.

What is this episode about?

The FDA granted Priority Review to trastuzumab deruxtecan for high-risk HER2-positive early breast cancer with residual disease, signaling a potential new standard to reduce recurrence risk.

Can I download this TheBrief.Health episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!